Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
A seasoned Mission Produce director just bought a substantial block of shares, signaling confidence in AVO. This arti...
Taiwan Semiconductor Manufacturing Co. is generating buzz as May 2026 results show strong growth and traders wonder i...
After years of setbacks, Intel appears to be turning a corner on its AI ambitions. This article breaks down what to w...
Stocks hover near the flat line as a cooler payrolls report shapes trading. The S&P 500 stalls while investors assess...
J.P. Morgan updates its U.S. Analyst Focus List for July, spotlighting a dependable dividend payer. The move comes as...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
SpaceX shares have tumbled from their peak, trading around $125 as of mid-July 2026. Analysts debate whether the retr...
A longtime dividend grower is resurfacing in the spotlight after a 25% price pullback. With a higher-than-Treasury yi...
NRG Energy surges to the lead in 2025, driven by Larry Coben’s leadership and a strategy to pair robust gas-fired gen...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...